MORRISVILLE, North Carolina, January 25, 2017 /PRNewswire/ --
"We're delighted to welcome Margo to the Worldwide team. She is an outstanding Quality Assurance (QA) leader who has the right mix of skills, passion and leadership expertise to ensure that our work is held to the absolute highest quality standards," said Peter Benton, President and COO at Worldwide. "Quality is the backbone of our company and is what our customers expect and demand. From her time as a bedside critical care nurse and lead CRA, to leadership roles in clinical operations and QA, along with her auditing and compliance activities - Margo's rich and diverse experience is exactly what we need."
In her new role, Holland will be responsible for the implementation of a risk-based clinical quality management system to ensure compliance with international regulations for Worldwide's full range of services and activities associated with the management or conduct of clinical trials, including clinical and medical monitoring, project management, data management, pharmacovigilance, depot services, and biostatistics. As global head of Quality, Holland will lead the QA organization as a trusted partner to support the company's efforts to change the quality of patients' lives, by ensuring that safe and effective medicines are available in a timely manner.
Holland's career has encompassed a variety of leadership roles within contract research organizations (CROs) and pharmaceutical companies. Prior to joining Worldwide, Holland served as the Quality Assurance head of Good Clinical Practices (GCP), Good Pharmacoepidemiology Practices (GPP) and, most recently, head of Good Laboratory Practices (GLP) for Vertex Pharmaceuticals Inc., where she was a key to the strategy development and deployment of the company's GxP Quality Management System. This ranged from strategic enhancement to strategic development, implementation and oversight of all quality activities within GCP, GPP and GLP.
Connect with Worldwide Clinical Trials:
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.worldwide.com.
SOURCE Worldwide Clinical Trials
Advertisement
Margo Holland has been named as the Vice President of Global Quality at Worldwide Clinical Trials (http://www.worldwide.com). This appointment demonstrates Worldwide's commitment to ensuring high standards of quality are met on behalf of its customers around the world.
Advertisement
"We're delighted to welcome Margo to the Worldwide team. She is an outstanding Quality Assurance (QA) leader who has the right mix of skills, passion and leadership expertise to ensure that our work is held to the absolute highest quality standards," said Peter Benton, President and COO at Worldwide. "Quality is the backbone of our company and is what our customers expect and demand. From her time as a bedside critical care nurse and lead CRA, to leadership roles in clinical operations and QA, along with her auditing and compliance activities - Margo's rich and diverse experience is exactly what we need."
In her new role, Holland will be responsible for the implementation of a risk-based clinical quality management system to ensure compliance with international regulations for Worldwide's full range of services and activities associated with the management or conduct of clinical trials, including clinical and medical monitoring, project management, data management, pharmacovigilance, depot services, and biostatistics. As global head of Quality, Holland will lead the QA organization as a trusted partner to support the company's efforts to change the quality of patients' lives, by ensuring that safe and effective medicines are available in a timely manner.
Holland's career has encompassed a variety of leadership roles within contract research organizations (CROs) and pharmaceutical companies. Prior to joining Worldwide, Holland served as the Quality Assurance head of Good Clinical Practices (GCP), Good Pharmacoepidemiology Practices (GPP) and, most recently, head of Good Laboratory Practices (GLP) for Vertex Pharmaceuticals Inc., where she was a key to the strategy development and deployment of the company's GxP Quality Management System. This ranged from strategic enhancement to strategic development, implementation and oversight of all quality activities within GCP, GPP and GLP.
Connect with Worldwide Clinical Trials:
- Tweet: Margo Holland announced as new Vice President of Global Quality Assurance @worldwidetrials
- Follow us on Twitter: @worldwidetrials
- Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.worldwide.com.
SOURCE Worldwide Clinical Trials
